UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000026364
Receipt number R000030293
Scientific Title The effect of acotiamide on gastroesophageal reflux events and reflux symptoms in patients with refractory gastroesophageal reflux disease (GERD) who are taking acid suppressive drugs
Date of disclosure of the study information 2017/03/03
Last modified on 2019/02/04 15:44:08

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The effect of acotiamide on gastroesophageal reflux events and reflux symptoms in patients with refractory gastroesophageal reflux disease (GERD) who are taking acid suppressive drugs

Acronym

The effect of acotiamide for refractory GERD

Scientific Title

The effect of acotiamide on gastroesophageal reflux events and reflux symptoms in patients with refractory gastroesophageal reflux disease (GERD) who are taking acid suppressive drugs

Scientific Title:Acronym

The effect of acotiamide for refractory GERD

Region

Japan


Condition

Condition

Gastroesophageal reflux disease

Classification by specialty

Gastroenterology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the effect of acotiamide for refractory GERD

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Others

Trial characteristics_2

Others

Developmental phase

Phase IV


Assessment

Primary outcomes

Subject's global assessment of overall treatment efficacy at 2 weeks

Key secondary outcomes

Patients rated of each symptoms at 2 weeks
Change of reflux pattern at 2 weeks


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification

NO

Dynamic allocation

NO

Institution consideration

Institution is not considered as adjustment factor.

Blocking

NO

Concealment

Central registration


Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

acotiamide 300mg 2 weeks

Interventions/Control_2

Placebo 2 weeks

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Gastric acid inhibitor refractory GERD

Key exclusion criteria

Patients with severe complications

Target sample size

100


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Hiroshi Yamashita

Organization

Saiseikai Nakatsu Hospital

Division name

Gastroenterology

Zip code


Address

Shibata Kitaku Osaka

TEL

0603520333

Email

onakaryoko0310@gmail.com


Public contact

Name of contact person

1st name
Middle name
Last name Hiroshi Yamasita

Organization

Saiseikai Nakatsu Hospital

Division name

Gastroenterology

Zip code


Address

Shibata Kitaku Osaka

TEL

0663520333

Homepage URL


Email

onakaryoko0310@gmail.com


Sponsor or person

Institute

saiseikai nakatsu hospital

Institute

Department

Personal name



Funding Source

Organization

non

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor

Shimane Univercity

Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

大阪府済生会中津病院(大阪府)
島根大学(島根県)


Other administrative information

Date of disclosure of the study information

2017 Year 03 Month 03 Day


Related information

URL releasing protocol


Publication of results

Published


Result

URL related to results and publications

http://links.springernature.com/f/a/HhO_T4LtwsmzFQ0pcn0P-Q~~/AABE5gA~/RgRd2b7iP0QwaHR0cDovL3d3dy5zcH

Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2015 Year 06 Month 01 Day

Date of IRB


Anticipated trial start date

2015 Year 06 Month 01 Day

Last follow-up date

2018 Year 12 Month 31 Day

Date of closure to data entry

2018 Year 12 Month 31 Day

Date trial data considered complete

2018 Year 12 Month 31 Day

Date analysis concluded

2018 Year 12 Month 31 Day


Other

Other related information



Management information

Registered date

2017 Year 03 Month 02 Day

Last modified on

2019 Year 02 Month 04 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000030293


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name